IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma

IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is an aggressive skin cancer with frequent metastasis; however, effective treatment options for advanced disease are often lacking. In this study, we investigated the clinical significance and functional impact of IGF2 mRNA-binding protein 3 (IGF2BP3) in MCC. Our results...

Full description

Saved in:
Bibliographic Details
Main Authors: Yajie Yang, Jiwei Gao, Hao Shi, Harri Sihto, Sami Kilpinen, François Vilcot, Libuse Janská, Jakob Jeschonneck, Todor Cvetanovic, Anders Höög, Jan Siarov, John Paoli, C. Christofer Juhlin, Lisa Villabona, Catharina Larsson, Weng-Onn Lui
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JID Innovations
Subjects:
Biomarker
IGF2BP3
Merkel cell carcinoma
Metastasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2667026725000098
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items